If you take more Quetiapina Qualigen than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or nearest hospital immediately. Bring your Quetiapina Qualigen tablets with you. You can also call the Toxicological Information Service, Tf: 915620420, indicating the medication and the amount taken.
If you forget to take Quetiapina Qualigen
If you forget to take a dose, take it as soon as you remember. If it is almost time to take the next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Quetiapina Qualigen
If you stop taking Quetiapina Qualigen abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before interrupting treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common side effects (may affect more than 1 in 10 people):
·Dizziness (may lead to falls), headache, dry mouth.
·Sensation of drowsiness (which may disappear over time as you continue to take quetiapine), (may lead to falls).
·Withdrawal symptoms (symptoms that occur when you stop taking quetiapine), which include insomnia, nausea, headache, diarrhea, vomiting, dizziness, and irritability. A gradual withdrawal over a period of at least 1 to 2 weeks is recommended.
·Weight gain.
·Abnormal muscle movements. These include difficulty initiating muscle movements, tremors, sensation of restlessness or muscle rigidity without pain.
·Changes in the amount of certain fats (triglycerides and total cholesterol).
Common side effects (may affect up to 1 in 10 people):
·Fast heart rate.
·Feeling like your heart is beating strongly, rapidly, or irregularly.
·Constipation, indigestion.
·Sensation of weakness.
·Swelling of arms or legs.
·Low blood pressure when standing. This may cause you to feel dizzy or faint (may lead to falls).
·Increased blood sugar levels.
·Blurred vision.
·Abnormal dreams and nightmares.
·Feeling hungrier.
·Feeling irritable.
·Speech and language disorder.
·Thoughts of suicide and worsening of depression.
·Shortness of breath.
·Vomiting (mainly in elderly people).
·Fever.
·Changes in the amount of thyroid hormones in the blood.
·Decrease in the number of certain types of blood cells.
·Increases in liver enzymes measured in the blood.
·Increases in prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to:
oBoth men and women having breast swelling and unexpected milk production.
oIn women, not having a menstrual period or having irregular periods.
Uncommon side effects (may affect up to 1 in 100 people):
·Seizures or convulsions.
·Allergic reactions that may include hives, skin swelling, and swelling around the mouth.
·Unpleasant sensations in the legs (also known as restless leg syndrome).
·Difficulty swallowing.
·Uncontrolled movements, mainly of the face or tongue.
·Sexual dysfunction.
·Diabetes.
·Prolongation of the QT interval seen on the ECG.
·Slower than normal heart rate that may occur at the start of treatment and may be associated with low blood pressure and fainting.
·Difficulty urinating.
·Fainting (may lead to falls).
·Stuffy nose.
·Decrease in the number of red blood cells in the blood.
·Decrease in the amount of sodium in the blood.
Rare side effects (may affect up to 1 in 1,000 people):
·A combination of high temperature (fever), sweating, muscle stiffness, feeling very drowsy or dizzy (a condition known as "neuroleptic malignant syndrome").
·Yellowish discoloration of the skin and eyes (jaundice).
·Inflammation of the liver (hepatitis).
·Prolonged and painful erection (priapism).
·Breast swelling and unexpected milk production (galactorrhea).
·Menstrual disorder.
·Clots in the veins, especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through the blood vessels to the lungs, causing chest pain and difficulty breathing. If you experience any of these symptoms, seek medical attention immediately.
·Walking, talking, eating, or other activities while you are asleep.
·Decreased body temperature (hypothermia).
·Inflammation of the pancreas.
·A condition (known as "metabolic syndrome") where you may experience a combination of 3 or more of the following effects: increased fat around your abdomen, decreased "good" cholesterol (HDL-C), increased levels of a type of fat in the blood called triglycerides, increased blood pressure, and increased blood sugar levels.
·A combination of fever, flu-like symptoms, sore throat, or any other infection with a very low white blood cell count, a condition known as agranulocytosis.
·Intestinal obstruction.
·Increased creatine phosphokinase in the blood (a substance found in muscles).
Very rare side effects (may affect up to 1 in 10,000 people):
·Severe rash, blisters, or red spots on the skin.
·Severe allergic reaction (known as anaphylaxis) that may cause difficulty breathing or shock.
·Quick swelling of the skin, usually around the eyes, lips, and throat (angioedema).
·Severe skin condition known as Stevens-Johnson syndrome.
·Unusual secretion of a hormone that controls urine volume.
·Breakdown of muscle fibers and muscle pain (rhabdomyolysis).
·Worsening of pre-existing diabetes.
Unknown (frequency cannot be estimated from available data):
·Red rash with irregular red spots (erythema multiforme).
·Severe allergic reaction with symptoms such as fever and blisters on the skin and peeling of the skin (toxic epidermal necrolysis).
·Symptoms of withdrawal in newborn babies of mothers who have used quetiapine during pregnancy.
·Medication-induced rash with eosinophilia and systemic symptoms (DRESS, for short). Generalized rash, high body temperature, elevated liver enzymes, blood abnormalities (eosinophilia), swollen lymph nodes, and other organs involved. If you develop these symptoms, stop using quetiapine and contact your doctor or seek medical attention immediately.
·Heart muscle disorder (cardiomyopathy)
·Inflammation of the heart muscle (myocarditis)
·Inflammation of blood vessels (vasculitis), often with a rash of small red or purple spots.
The class of medications to which Quetiapine Qualigen belongs can cause serious heart rhythm problems that can be life-threatening.
Some side effects are only seen when blood tests are done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increases in liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increases in creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to:
·Both men and women having breast swelling and unexpected milk production.
·In women, not having a menstrual period or having irregular periods.
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects (may affect more than 1 in 10 people):
·Increased amount of a hormone called prolactin in the blood. Increases in prolactin hormone may, in rare cases, lead to:
-Both boys and girls having breast swelling and unexpected milk production.
-In girls, not having a menstrual period or having irregular periods.
·Increased appetite.
·Vomiting.
·Abnormal muscle movements. These include difficulty initiating muscle movements, tremors, sensation of restlessness or muscle rigidity without pain.
·Increased blood pressure.
Common side effects (may affect up to 1 in 10 people):
·Sensation of weakness, fainting (may lead to falls).
·Stuffy nose.
·Feeling irritable.
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https//www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Thismedication does not require any special storage temperature. Store in the original packaging to protect from humidity.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE drop-off point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
The active ingredient is quetiapine. The tablets contain 200 mg of quetiapine (as quetiapine fumarate).
The other components are:
Core of the tablet: hypromellose, microcrystalline cellulose, anhydrous sodium citrate, magnesium stearate
Coating of the tablet: hypromellose, titanium dioxide (E-171), macrogol 400, polysorbate 80, yellow iron oxide (E-172), red iron oxide (E-172).
Appearance of the product and contents of the packaging
The tablets are yellow in color and have "Q 200" engraved on one side.
They are presented in PVC/PVDC – Aluminum blisters, in packaging of 10, 30, 50, 60, and 100 tablets.
They are also presented in white opaque high-density polyethylene bottles provided with a white opaque polypropylene cap with desiccant, in packaging of 60 tablets.
Only some packaging sizes may be commercially available.
Marketing authorization holder
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona - Spain
Responsible for manufacturing
Merckle GmbH
Ludwig-Merckle Strasse 3
D-89143 Blaubeuren-Weiler
Germany
Teva UK
Bra mpton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG
United Kingdom
Last review date of this leaflet: June 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.